AIM ImmunoTech Statistics

Total Valuation

AIM ImmunoTech has a market cap or net worth of $7.65 million. The enterprise value is $6.68 million.

Market Cap	7.65M
Enterprise Value	6.68M

Important Dates

The last earnings date was Thursday, March 27, 2025, before market open.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM ImmunoTech has 63.78 million shares outstanding. The number of shares has increased by 15.30% in one year.

Current Share Class	63.78M
Shares Outstanding	63.78M
Shares Change (YoY)	+15.30%
Shares Change (QoQ)	+10.99%
Owned by Insiders (%)	10.40%
Owned by Institutions (%)	7.29%
Float	53.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.88
Forward PS	n/a
PB Ratio	-5.84
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	39.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.44

Current Ratio	0.44
Quick Ratio	0.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.80

Financial Efficiency

Return on equity (ROE) is -388.69% and return on invested capital (ROIC) is -196.60%.

Return on Equity (ROE)	-388.69%
Return on Assets (ROA)	-88.30%
Return on Invested Capital (ROIC)	-196.60%
Return on Capital Employed (ROCE)	2,132.90%
Revenue Per Employee	$6,071
Profits Per Employee	-$618,571
Employee Count	28
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.69% in the last 52 weeks. The beta is 0.41, so AIM ImmunoTech's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-72.69%
50-Day Moving Average	0.15
200-Day Moving Average	0.25
Relative Strength Index (RSI)	40.80
Average Volume (20 Days)	549,910

Short Selling Information

The latest short interest is 3.17 million, so 4.97% of the outstanding shares have been sold short.

Short Interest	3.17M
Short Previous Month	3.41M
Short % of Shares Out	4.97%
Short % of Float	5.90%
Short Ratio (days to cover)	3.10

Income Statement

In the last 12 months, AIM ImmunoTech had revenue of $170,000 and -$17.32 million in losses. Loss per share was -$0.31.

Revenue	170,000
Gross Profit	139,000
Operating Income	-19.77M
Pretax Income	-31.12M
Net Income	-17.32M
EBITDA	-19.53M
EBIT	-19.77M
Loss Per Share	-$0.31

Full Income Statement

Balance Sheet

The company has $3.98 million in cash and $2.94 million in debt, giving a net cash position of $1.04 million or $0.02 per share.

Cash & Cash Equivalents	3.98M
Total Debt	2.94M
Net Cash	1.04M
Net Cash Per Share	$0.02
Equity (Book Value)	-1.32M
Book Value Per Share	-0.02
Working Capital	-5.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.89 million and capital expenditures -$18,000, giving a free cash flow of -$14.91 million.

Operating Cash Flow	-14.89M
Capital Expenditures	-18,000
Free Cash Flow	-14.91M
FCF Per Share	-$0.23

Full Cash Flow Statement

Margins

Gross Margin	81.76%
Operating Margin	-11,630.59%
Pretax Margin	-10,188.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM ImmunoTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.30%
Shareholder Yield	n/a
Earnings Yield	-224.43%
FCF Yield	-193.15%

Analyst Forecast

The average price target for AIM ImmunoTech is $2.75, which is 2,191.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.75
Price Target Difference	2,191.67%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	189.24%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 11, 2019. It was a reverse split with a ratio of 0.022727273:1.

Last Split Date	Jun 11, 2019
Split Type	Reverse
Split Ratio	0.022727273:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2